Third Coast Bancshares, Inc. current report, 25 May 2023

Form 8-K Summary

Company: Third Coast Bancshares, Inc. (Nasdaq: TCBX)
Report date: May 25, 2023; signed May 26, 2023
Reporting context: Annual shareholder meeting and related corporate actions. The filing does not report quarterly or annual financial results.

Material Corporate Actions

  • Shareholders approved an amendment and restatement of Article VI of the certificate of formation authorizing a new class of $1.00 par value non-voting common stock. The amendment became effective upon filing with the Texas Secretary of State on May 25, 2023.
  • Shareholders approved, for Nasdaq Listing Rule 5635(d) purposes, potential issuance of common stock or, where applicable, non-voting common stock upon conversion of Series A Convertible Non-Cumulative Preferred Stock and Series B Convertible Perpetual Preferred Stock, and upon exercise of warrants for an aggregate of 175,000 shares at an exercise price of $22.50 per share.
  • Whitley Penn LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2023, with 8,824,456 votes for, 1,995,420 against, and 4,499 abstentions.

Board Election Results

DirectorForAgainstAbstainBroker non-votes
W. Donald Brunson5,632,8223,337,300583,0201,271,233
Bart O. Caraway6,111,9122,860,710580,5201,271,233
Shelton J. McDonald6,882,9342,079,712590,4961,271,233
Tony Scavuzzo7,745,5791,799,8647,6991,271,233

All four nominees were elected as Class A directors to serve until the 2026 annual meeting and until their successors are elected and qualified, or until earlier resignation or removal.

Financial Metrics and Liquidity

The filing does not provide revenue, net income, cash flow, margins, debt, liquidity, capital, asset quality, or other operating metrics. It also does not provide management guidance or a financial outlook.

Investor Considerations

  • The new non-voting common stock class may provide additional flexibility for future financing, conversions, or other transactions, but the filing does not specify any immediate issuance.
  • Potential conversion and warrant exercises could result in the issuance of additional equity securities and possible dilution to existing common shareholders.
  • The approved securities issuance relates to preferred-stock conversion rights and warrants; investors should review the governing instruments and the attached Certificate of Amendment for the detailed terms.

Facts to Verify

  • Review Exhibit 3.1 for the precise rights, preferences, and limitations of the new non-voting common stock.
  • Confirm the terms and potential share count associated with Series A and Series B preferred-stock conversions.
  • Review the warrant agreement, including the 175,000-share aggregate amount and $22.50 exercise price.
  • Assess any future filings for actual issuances, conversions, warrant exercises, or resulting shareholder dilution.